Wells Fargo’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3K Sell
10,628
-21,836
-67% -$43.9K ﹤0.01% 5871
2025
Q4
$84.4K Buy
32,464
+11,427
+54% +$31.2K ﹤0.01% 5443
2025
Q3
$63.1K Buy
21,037
+2,407
+13% +$8.6K ﹤0.01% 5485
2025
Q2
$74.9K Buy
18,630
+5,600
+43% +$20.7K ﹤0.01% 5357
2025
Q1
$43.4K Buy
13,030
+288
+2% +$1.37K ﹤0.01% 5448
2024
Q4
$78.7K Buy
12,742
+4,243
+50% +$24.7K ﹤0.01% 5324
2024
Q3
$47.4K Sell
8,499
-297
-3% -$1.98K ﹤0.01% 5357
2024
Q2
$65.7K Buy
8,796
+4,063
+86% +$25.1K ﹤0.01% 5176
2024
Q1
$27.5K Buy
4,733
+593
+14% +$2.97K ﹤0.01% 5476
2023
Q4
$20.5K Buy
4,140
+959
+30% +$4.94K ﹤0.01% 5631
2023
Q3
$16.3K Sell
3,181
-2,412
-43% -$14.2K ﹤0.01% 5671
2023
Q2
$37.8K Buy
5,593
+5,537
+9,888% +$32.8K ﹤0.01% 5533
2023
Q1
$347 Buy
56
+12
+27% +$54 ﹤0.01% 6629
2022
Q4
$164 Buy
+44
New +$184 ﹤0.01% 6681

Other funds holding BTMD

Wells Fargo's BTMD Position: Q1 2026 in Review

Wells Fargo reduced its Biote Corp (BTMD) stake by 67% in Q1 2026, selling an estimated $43.9K and leaving 10,628 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5871.

Wells Fargo first reported a position in BTMD in Q4 2022 and has held it in 14 quarters since. The position peaked at $84.4K in Q4 2025. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • Wells Fargo held 10,628 shares of Biote Corp worth $14.3K as of Q1 2026.
  • Wells Fargo sold 21,836 Biote Corp shares in Q1 2026, an estimated $43.9K.
  • Biote Corp made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5871 holding.
  • Wells Fargo first reported a position in Biote Corp in Q4 2022 and has held it in 14 quarters since.
  • Wells Fargo's Biote Corp position peaked at $84.4K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.